Cellular Therapies in Hematologic Malignancies: Trends & Market Access Implications Across Care Settings January 29, 2026
Delivering Real World Evidence That Matters to Payers: Insights from a Survey of Access Decision Makers January 14, 2026
FDA’s Plausible Mechanism Pathway: A Regulatory Shift with Significant Market Access Implications December 17, 2025
What’s Really Driving Your Brand’s Performance? A Practical Guide to Local Market Dynamics October 17, 2025
What’s Missing from Your Coverage Conversations? 4 Ways to Help Reps Turn Data into Action September 22, 2025
The Power of Alignment: Why Biotech Milestones Demand an Integrated IR + PR Strategy September 8, 2025
Understanding the Medicare Part D Redesign Impact on Pharma: A Strategic Modeling Approach August 15, 2025
Innovation, Personalization, and the Future of Oncology: How AI Is Transforming Cancer Care June 25, 2025
The Price of Progress: Unpacking the Trump Administration’s Drug Pricing Executive Order May 22, 2025
Through a glass darkly: The what, how, and what now for global net price transparency February 13, 2025